OnKure Therapeutics, Inc. (OKUR)
3.54
-0.02
(-0.56%)
USD |
NASDAQ |
Sep 02, 16:00
3.54
0.00 (0.00%)
After-Hours: 20:00
OnKure Therapeutics Research and Development Expense (Annual) : 47.81M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 47.81M |
| December 31, 2024 | 43.34M |
| December 31, 2023 | 31.70M |
| December 31, 2022 | 37.18M |
| Date | Value |
|---|---|
| December 31, 2021 | 28.12M |
| December 31, 2020 | 15.91M |
| December 31, 2019 | 13.06M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| Theriva Biologics, Inc. | 8.604M |
| Nkarta, Inc. | 81.24M |
| Unicycive Therapeutics, Inc. | 9.121M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |